Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity

Tumor antigen (TA)-targeting monoclonal antibody (mAb)-based treatments are considered to be one of the most successful strategies in cancer therapy. Besides targeting TAs and inducing tumor cell death, such antibodies interact with immune cells through Fc-dependent mechanisms to induce adaptive mem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Michaud, Henri-Alexandre, Eliaou, Jean-François, Lafont, Virginie, Bonnefoy, Nathalie, Gros, Laurent
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292589/
https://ncbi.nlm.nih.gov/pubmed/25941618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.955684
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars